Trista Morrison
Personalreferent bei VOYAGER THERAPEUTICS, INC.
Profil
Trista Morrison is currently the Director at Network of Tyrosinemia Advocates, Inc. and the Chief of Staff & SVP Corporate Affairs at Voyager Therapeutics, Inc. She previously worked as the Director-Corporate Communications at Ironwood Pharmaceuticals, Inc., the Head-Media Relations at Gemin X Pharmaceuticals US, Inc., and the Chief Communications Officer at Saniona AB.
Ms. Morrison completed her undergraduate degree at Tulane University (Louisiana).
Aktive Positionen von Trista Morrison
| Unternehmen | Position | Beginn |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Personalreferent | - |
| Network of Tyrosinemia Advocates, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Trista Morrison
| Unternehmen | Position | Ende |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Public Communications Contact | - |
| SANA AB | Public Communications Contact | - |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Public Communications Contact | - |
Ausbildung von Trista Morrison
| Tulane University (Louisiana) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| SANA AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
| Network of Tyrosinemia Advocates, Inc. |
